Navigation Links
Patients' Remote(ly) Monitored: Ask Frost & Sullivan, What Is Driving the European Market
Date:3/24/2009

LONDON, March 24 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Remote Patient Monitoring Market to be held on Tuesday, 31st March 2009, at 2 p.m. GMT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

The world is facing an ongoing healthcare crisis along with the global economic slowdown. The timing could not be any worse: mounting costs, a steady increase regarding the ageing population, dysfunctional reimbursement policies, limited access, an ever impending physician shortage and concerns over quality of care are just some of the concerns.

In times like these, the focus should move to promising new technologies, which hold a lot of potential. Remote patient monitoring technologies are increasingly being recognized as valuable tools for enhancing quality care in chronic disease management. They have the potential to deliver new and unimaginable savings for both patients and providers. Unfortunately though, consumers remain woefully ignorant of the performance ability of these technologies, even though they could help them not only improve their health, but also manage it.

Highlights of the Frost & Sullivan briefing include the discussion of: current trends, challenges, drivers and restraints, significant market developments, revenue forecasts and a look on to the road ahead. The briefing will benefit service providers, equipment vendors, distributors and physicians by discussing various factors influencing the market and highlighting the emerging trends.

"The heightened demands of an ageing population and a related increase in chronic diseases are helping the remote patient monitoring market growth. It has the potential to change the way patients manage their own conditi
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New data on cancer survival in Europe show more patients are cured
2. Super micro-surgery offers new hope for breast cancer patients with lymphedema
3. Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients
4. Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
5. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
6. Focus on treating malnutrition in cancer patients, researchers say
7. Malnutrition risk underappreciated in laryngeal cancer patients
8. Stent 4 Life: A campaign is launched to increase the use of primary PCI in acute coronary patients
9. Abnormal EKG can predict death in stroke patients
10. Band Aid Mini Facelift Developed by Atlanta Plastic Surgeon John L. LeRoy, MD can Help Patients Look Younger for Less Money
11. Pitt vaccine to prevent colon cancer being tested in patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Seattle, Wa (PRWEB) July 14, 2014 According ... Vkool.com, this is a helpful guide that features a series ... Vkool exposes in its review that this book can help ... common causes of high blood pressure, and effective methods to ... as they are reviewed now by Vkool, was penned by ...
(Date:7/14/2014)... Vaginal Mesh lawsuit claims continue ... pelvic mesh manufacturers in the U.S. District Court, Southern ... The federal complaints are pending against pelvic mesh manufacturers ... Systems (MDL No. 2325), and C.R. Bard, Inc., (MDL ... Vaginal Mesh lawsuit claims pending, according to statistics from ...
(Date:7/14/2014)... 14, 2014 TherapySites, ... mental health professionals, announced today its affiliation with ... Carolina (LPCANC). This new relationship allows TherapySites ... to LPCANC members, adding exclusive benefits and promotional ... have been dedicated to providing online marketing solutions ...
(Date:7/14/2014)... Townsend Security, a leading authority ... IBM i (AS/400, iSeries) Two Factor Authentication Partner ... threats evolve and make passwords ineffective for system ... their applications and implement two factor authentication (2FA). ... for ISVs on the IBM i platform to ...
(Date:7/13/2014)... N.J. – Authors Leonard I. Linkow and Sheldon ... implants in their book Renaissance of the ... techniques in the world of dentistry and reviews conventional and ... of their natural teeth. , Dr. Gustav Dahl of ... It was a mesh frame fabricated from stainless steel ...
Breaking Medicine News(10 mins):Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 4Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 5Health News:TherapySites Partners With the Licensed Professional Counselors Association of North Carolina to Make Online Marketing Available to All Therapists 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4
... may be more prone to an alcohol-induced headache after ... Jefferson Headache Center. The research will be presented at ... Neuroscience, in Chicago. Until now, studying the mechanism ... not been possible in an animal model, according to ...
... Macrophages, the scavenger cells of the body,s immune ... University School of Medicine researchers have identified one pathway ... causes a lupuslike autoimmune disease. The findings could ... of lupus in humans and potential drug treatments for ...
... e cigarettes sales have generally been tobacco smoking individuals ... online sales associate for E-Cigarettes National, reports an influx ... loved ones that smoke. "Some of these callers are ... starter kit for their spouses or partners that have ...
... is important to many who undergo weight-reduction surgery, study finds ... obese -- a step above overweight -- by the age ... polycystic ovarian syndrome than others, new research suggests. , ... than women who become obese when they,re older, according to ...
... cookie diets recently featured in the media have been criticized ... Smart for Life Cookie Diet should not be grouped in ... that are all-natural, 60% organic, and filled with nutrients and ... that has become much more than a simple cookie diet ...
... open enrollment season, and millions of employees are focusing ... a serious health issue strikes, it isn,t enough to ... on making sure you,re prepared to weather the storm ... this report from Guardian at: http://inr.mediaseed.tv/oneClip_C/?feed=BJ5vKAI3hMPsemBun4FIM6cBCcDeE0bZ ...
Cached Medicine News:Health News:Migraine sufferers more prone to hangover headache 2Health News:Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice 2Health News:Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice 3Health News:Online Sales of E Cigarettes Expected to Rise Over the Holidays 2Health News:Obesity May Affect Fertility in Young Women 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 3
(Date:7/14/2014)...  Mylan Inc. (NASDAQ: MYL ) today announced ... Abbott (NYSE: ABT ) whereby ... markets specialty and branded generics business ("the Assets") in an ... receive 105 million shares of the combined company worth approximately ... Friday, July 11, 2014, representing an approximately 21% ownership stake. ...
(Date:7/11/2014)... , July 11, 2014 Patient ... marketing and, consequently, organizations are turning to an ... As part of this evolving approach ... to educate, communicate and engage patients throughout their ... to patient empowerment. By mapping the patient journey ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... "Global Hypodermic Needles Market 2014-2018" report to ... A hypodermic needle is a hollow needle ... the body or or to extract fluids from it. ... liquids or to inject substances that cannot be ingested. ...
Breaking Medicine Technology:Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... International Myeloma Workshop held in,Kos, Greece ... with bortezomib, dexamethasone and lenalidomide plus,dexamethasone, ... as a single agent in patients ... 29, 2007 /PRNewswire-FirstCall/ -- Keryx,Biopharmaceuticals, Inc. ...
... 2007--A cervical cancer vaccine has shown 90%,efficacy for prevention ... papillomavirus (HPV) types targeted by,the vaccine, conclude authors of ... of The Lancet., HPV types 16 and 18 account ... there are up to 15,oncogenic HPV types which can ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
OKN drum...
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3...
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile...
The rectangular large-field lens of the 2631 are ideal for reading and writing....
Medicine Products: